Secondary Metabolites from Food-Derived Yeasts Inhibit Virulence of <named-content content-type="genus-species">Candida albicans</named-content>

ABSTRACT A sparse number of available antifungal drugs, therapeutic side effects, and drug resistance are major challenges in current antifungal therapy to treat Candida albicans-associated infections. Here, we describe two food-derived yeasts, Saccharomyces cerevisiae and Issatchenkia occidentalis,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lohith Kunyeit, Nawneet K. Kurrey, K. A. Anu-Appaiah, Reeta P. Rao
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/c0108ff4dc6241c7a072179e6360ff8f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c0108ff4dc6241c7a072179e6360ff8f
record_format dspace
spelling oai:doaj.org-article:c0108ff4dc6241c7a072179e6360ff8f2021-11-10T18:37:52ZSecondary Metabolites from Food-Derived Yeasts Inhibit Virulence of <named-content content-type="genus-species">Candida albicans</named-content>10.1128/mBio.01891-212150-7511https://doaj.org/article/c0108ff4dc6241c7a072179e6360ff8f2021-08-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01891-21https://doaj.org/toc/2150-7511ABSTRACT A sparse number of available antifungal drugs, therapeutic side effects, and drug resistance are major challenges in current antifungal therapy to treat Candida albicans-associated infections. Here, we describe two food-derived yeasts, Saccharomyces cerevisiae and Issatchenkia occidentalis, that inhibit virulence traits of C. albicans, including hyphal morphogenesis, biofilm formation, and adhesion to intestinal epithelial cells. These yeasts also protect the model host Caenorhabditis elegans from C. albicans infection. We demonstrate that the protective activity is primarily retained in the secretome of the beneficial yeasts, and the protection they provide as a physical barrier is negligible. S. cerevisiae aro8 aro9 mutant analysis demonstrate that phenylethanol and tryptophol are necessary for protection, and experiments with commercially procured compounds indicate that they are sufficient to inhibit C. albicans virulence. We propose food-derived yeasts as an alternative or combination therapy to conventional antifungal therapy for C. albicans infection. IMPORTANCE The gut microbiome, primarily established by food, is complex and contributes to the health of the host. Molecular mechanisms that regulate microbial interactions and host health remain unclear. Here, we show that the pathogen C. albicans interacts with food-derived beneficial yeasts in the gut of the microscopic worm, C. elegans, forming a simple microbiome. C. albicans can colonize the worm gut, compromising the worm’s health, and exposure to the food-derived yeasts ameliorates this effect protecting the nematode host. We identify small molecules from food-derived yeasts that are necessary and sufficient to inhibit multiple virulence traits of C. albicans and protect the nematode host. The nematode gut faithfully recapitulates a mammalian intestine. This could be an effective alternative or combination therapy for C. albicans infection.Lohith KunyeitNawneet K. KurreyK. A. Anu-AppaiahReeta P. RaoAmerican Society for Microbiologyarticlebeneficial microbesaromatic alcoholsCandida albicans biofilmadhesionCaco-2 cell monolayerCaenorhabditis elegansMicrobiologyQR1-502ENmBio, Vol 12, Iss 4 (2021)
institution DOAJ
collection DOAJ
language EN
topic beneficial microbes
aromatic alcohols
Candida albicans biofilm
adhesion
Caco-2 cell monolayer
Caenorhabditis elegans
Microbiology
QR1-502
spellingShingle beneficial microbes
aromatic alcohols
Candida albicans biofilm
adhesion
Caco-2 cell monolayer
Caenorhabditis elegans
Microbiology
QR1-502
Lohith Kunyeit
Nawneet K. Kurrey
K. A. Anu-Appaiah
Reeta P. Rao
Secondary Metabolites from Food-Derived Yeasts Inhibit Virulence of <named-content content-type="genus-species">Candida albicans</named-content>
description ABSTRACT A sparse number of available antifungal drugs, therapeutic side effects, and drug resistance are major challenges in current antifungal therapy to treat Candida albicans-associated infections. Here, we describe two food-derived yeasts, Saccharomyces cerevisiae and Issatchenkia occidentalis, that inhibit virulence traits of C. albicans, including hyphal morphogenesis, biofilm formation, and adhesion to intestinal epithelial cells. These yeasts also protect the model host Caenorhabditis elegans from C. albicans infection. We demonstrate that the protective activity is primarily retained in the secretome of the beneficial yeasts, and the protection they provide as a physical barrier is negligible. S. cerevisiae aro8 aro9 mutant analysis demonstrate that phenylethanol and tryptophol are necessary for protection, and experiments with commercially procured compounds indicate that they are sufficient to inhibit C. albicans virulence. We propose food-derived yeasts as an alternative or combination therapy to conventional antifungal therapy for C. albicans infection. IMPORTANCE The gut microbiome, primarily established by food, is complex and contributes to the health of the host. Molecular mechanisms that regulate microbial interactions and host health remain unclear. Here, we show that the pathogen C. albicans interacts with food-derived beneficial yeasts in the gut of the microscopic worm, C. elegans, forming a simple microbiome. C. albicans can colonize the worm gut, compromising the worm’s health, and exposure to the food-derived yeasts ameliorates this effect protecting the nematode host. We identify small molecules from food-derived yeasts that are necessary and sufficient to inhibit multiple virulence traits of C. albicans and protect the nematode host. The nematode gut faithfully recapitulates a mammalian intestine. This could be an effective alternative or combination therapy for C. albicans infection.
format article
author Lohith Kunyeit
Nawneet K. Kurrey
K. A. Anu-Appaiah
Reeta P. Rao
author_facet Lohith Kunyeit
Nawneet K. Kurrey
K. A. Anu-Appaiah
Reeta P. Rao
author_sort Lohith Kunyeit
title Secondary Metabolites from Food-Derived Yeasts Inhibit Virulence of <named-content content-type="genus-species">Candida albicans</named-content>
title_short Secondary Metabolites from Food-Derived Yeasts Inhibit Virulence of <named-content content-type="genus-species">Candida albicans</named-content>
title_full Secondary Metabolites from Food-Derived Yeasts Inhibit Virulence of <named-content content-type="genus-species">Candida albicans</named-content>
title_fullStr Secondary Metabolites from Food-Derived Yeasts Inhibit Virulence of <named-content content-type="genus-species">Candida albicans</named-content>
title_full_unstemmed Secondary Metabolites from Food-Derived Yeasts Inhibit Virulence of <named-content content-type="genus-species">Candida albicans</named-content>
title_sort secondary metabolites from food-derived yeasts inhibit virulence of <named-content content-type="genus-species">candida albicans</named-content>
publisher American Society for Microbiology
publishDate 2021
url https://doaj.org/article/c0108ff4dc6241c7a072179e6360ff8f
work_keys_str_mv AT lohithkunyeit secondarymetabolitesfromfoodderivedyeastsinhibitvirulenceofnamedcontentcontenttypegenusspeciescandidaalbicansnamedcontent
AT nawneetkkurrey secondarymetabolitesfromfoodderivedyeastsinhibitvirulenceofnamedcontentcontenttypegenusspeciescandidaalbicansnamedcontent
AT kaanuappaiah secondarymetabolitesfromfoodderivedyeastsinhibitvirulenceofnamedcontentcontenttypegenusspeciescandidaalbicansnamedcontent
AT reetaprao secondarymetabolitesfromfoodderivedyeastsinhibitvirulenceofnamedcontentcontenttypegenusspeciescandidaalbicansnamedcontent
_version_ 1718439811642032128